Tag: Esperion Therapeutics

“Venture capitalists in Michigan continue to grow in an environment where, in other parts of the country, the industry is contracting,” said a Managing Director of Arboretum Ventures and the outgoing chair of the Michigan Venture Capital Association.

Esperion Therapeutics, Inc., a clinical-stage biopharmaceutical company announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share

Xconomy presents “Michigan 2030” What will the Michigan innovation, life sciences, clean energy, transportation, and information technology landscape look like 20 years from now? Will the area have emerged as an even bigger player in university and corporate research, or a major factor at all in areas like venture financing and entrepreneurial activity-and, if so, […]